Topic
breast-reconstruction
1 stories related to this topic, newest first.
Benzingafinance60 days ago
Elutia Reports $3.1 Million in Q1 2026 Net Sales, Up 6% Year-over-Year
Elutia released first-quarter results on May 14, 2026, showing improved gross margin and progress on its automated manufacturing platform. The company anticipates FDA clearance for its NXT41 product in Q4 2026. CEO Randy Mills highlighted the $1.5 billion U.S. breast reconstructi…